nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—HTR2A—narcolepsy	0.8	1	CbGaD
Flupentixol—HTR2A—enteric nervous system—narcolepsy	0.0162	0.188	CbGeAlD
Flupentixol—HTR2A—locus ceruleus—narcolepsy	0.0107	0.124	CbGeAlD
Flupentixol—HTR2A—pons—narcolepsy	0.00616	0.0717	CbGeAlD
Flupentixol—HTR2A—autonomic nervous system—narcolepsy	0.00568	0.0661	CbGeAlD
Flupentixol—DDC—brainstem—narcolepsy	0.00479	0.0557	CbGeAlD
Flupentixol—DDC—forebrain—narcolepsy	0.00462	0.0538	CbGeAlD
Flupentixol—DRD1—brainstem—narcolepsy	0.00352	0.0409	CbGeAlD
Flupentixol—DRD1—forebrain—narcolepsy	0.0034	0.0395	CbGeAlD
Flupentixol—DDC—midbrain—narcolepsy	0.00305	0.0355	CbGeAlD
Flupentixol—CHRM1—forebrain—narcolepsy	0.00249	0.029	CbGeAlD
Flupentixol—DRD1—midbrain—narcolepsy	0.00224	0.0261	CbGeAlD
Flupentixol—ADRA1A—brainstem—narcolepsy	0.00212	0.0247	CbGeAlD
Flupentixol—DRD2—brainstem—narcolepsy	0.00208	0.0242	CbGeAlD
Flupentixol—ADRA1A—forebrain—narcolepsy	0.00205	0.0238	CbGeAlD
Flupentixol—DRD2—forebrain—narcolepsy	0.00201	0.0233	CbGeAlD
Flupentixol—DDC—brain—narcolepsy	0.00192	0.0223	CbGeAlD
Flupentixol—DRD1—brain—narcolepsy	0.00141	0.0164	CbGeAlD
Flupentixol—HTR2A—brainstem—narcolepsy	0.00137	0.016	CbGeAlD
Flupentixol—DRD2—midbrain—narcolepsy	0.00132	0.0154	CbGeAlD
Flupentixol—HTR2A—forebrain—narcolepsy	0.00132	0.0154	CbGeAlD
Flupentixol—CHRM1—brain—narcolepsy	0.00103	0.012	CbGeAlD
Flupentixol—Zuclopenthixol—HTR2A—narcolepsy	0.000985	0.229	CrCbGaD
Flupentixol—HTR2A—medulla oblongata—narcolepsy	0.000956	0.0111	CbGeAlD
Flupentixol—HTR2A—midbrain—narcolepsy	0.000874	0.0102	CbGeAlD
Flupentixol—ABCB1—forebrain—narcolepsy	0.000867	0.0101	CbGeAlD
Flupentixol—ADRA1A—brain—narcolepsy	0.000849	0.00988	CbGeAlD
Flupentixol—Thiothixene—HTR2A—narcolepsy	0.000849	0.197	CrCbGaD
Flupentixol—DRD2—brain—narcolepsy	0.000832	0.00969	CbGeAlD
Flupentixol—Fluphenazine—HTR2A—narcolepsy	0.000734	0.17	CrCbGaD
Flupentixol—ABCB1—medulla oblongata—narcolepsy	0.000626	0.00729	CbGeAlD
Flupentixol—Trifluoperazine—HTR2A—narcolepsy	0.000587	0.136	CrCbGaD
Flupentixol—Perphenazine—HTR2A—narcolepsy	0.00058	0.135	CrCbGaD
Flupentixol—ABCB1—midbrain—narcolepsy	0.000573	0.00666	CbGeAlD
Flupentixol—Quetiapine—HTR2A—narcolepsy	0.000569	0.132	CrCbGaD
Flupentixol—HTR2A—brain—narcolepsy	0.000549	0.00639	CbGeAlD
Flupentixol—ABCB1—brain—narcolepsy	0.00036	0.00419	CbGeAlD
Flupentixol—DRD1—GPCR ligand binding—PENK—narcolepsy	0.000342	0.00312	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00034	0.00311	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.000339	0.0031	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.000339	0.0031	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000339	0.0031	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000335	0.00306	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000334	0.00306	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000333	0.00305	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.000333	0.00304	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000331	0.00303	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.000328	0.003	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000326	0.00298	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.000318	0.0029	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000311	0.00284	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000311	0.00284	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.000309	0.00283	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.000309	0.00283	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.000304	0.00278	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.000304	0.00278	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0003	0.00274	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.000298	0.00273	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000295	0.00269	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.000292	0.00267	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TRH—narcolepsy	0.00029	0.00266	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00029	0.00265	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.000289	0.00265	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000288	0.00264	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000288	0.00263	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000285	0.0026	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000284	0.0026	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000283	0.00259	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.000283	0.00259	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000282	0.00258	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00028	0.00256	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.000279	0.00255	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000278	0.00254	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000278	0.00254	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000277	0.00254	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000277	0.00253	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000277	0.00253	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000276	0.00253	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000276	0.00253	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000272	0.00249	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000272	0.00249	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000264	0.00241	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000264	0.00241	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—PENK—narcolepsy	0.000258	0.00236	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.000255	0.00233	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—HRH3—narcolepsy	0.000255	0.00233	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000254	0.00232	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000252	0.00231	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.000252	0.00231	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CPT1B—narcolepsy	0.00025	0.00229	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.000248	0.00227	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000248	0.00227	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000247	0.00226	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000243	0.00222	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00024	0.00219	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.000239	0.00219	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.000239	0.00219	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—P2RY11—narcolepsy	0.000231	0.00211	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TRH—narcolepsy	0.000219	0.002	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HCRT—narcolepsy	0.000217	0.00198	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000216	0.00197	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.000215	0.00196	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000213	0.00195	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.000211	0.00193	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TAC1—narcolepsy	0.000211	0.00193	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—NPS—narcolepsy	0.000211	0.00193	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000209	0.00191	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000209	0.00191	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000206	0.00188	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000206	0.00188	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000205	0.00187	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000205	0.00187	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000202	0.00184	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000202	0.00184	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000199	0.00182	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000199	0.00182	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HCRT—narcolepsy	0.000197	0.0018	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000196	0.00179	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000196	0.00179	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000195	0.00178	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000195	0.00178	CbGpPWpGaD
Flupentixol—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000195	0.00178	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—PENK—narcolepsy	0.000193	0.00176	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000192	0.00176	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000192	0.00176	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000192	0.00175	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000192	0.00175	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000189	0.00173	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000189	0.00173	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.000188	0.00172	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.000188	0.00172	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000186	0.0017	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000185	0.00169	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000185	0.00169	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.000183	0.00167	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000181	0.00165	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000181	0.00165	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000178	0.00163	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000178	0.00163	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000177	0.00162	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000177	0.00162	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PENK—narcolepsy	0.000175	0.0016	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000175	0.0016	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000174	0.00159	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000174	0.00159	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000172	0.00157	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.000171	0.00156	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.000168	0.00154	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000167	0.00152	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000166	0.00152	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TRH—narcolepsy	0.000164	0.0015	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000164	0.0015	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000163	0.00149	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000161	0.00147	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00016	0.00146	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000159	0.00146	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000159	0.00146	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000158	0.00144	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000157	0.00143	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000157	0.00143	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.000156	0.00143	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.000156	0.00143	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.000153	0.0014	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.000153	0.0014	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TRH—narcolepsy	0.000149	0.00136	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000148	0.00136	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000147	0.00134	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000146	0.00134	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000146	0.00133	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.000145	0.00133	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000144	0.00132	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000144	0.00131	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000143	0.00131	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000143	0.00131	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000143	0.0013	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000142	0.00129	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000141	0.00129	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000141	0.00129	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00014	0.00128	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—P2RY11—narcolepsy	0.000137	0.00125	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000132	0.00121	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRH3—narcolepsy	0.000131	0.00119	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.00013	0.00119	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00013	0.00118	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.000127	0.00117	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000127	0.00116	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000126	0.00115	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000124	0.00113	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000123	0.00113	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000122	0.00111	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.000121	0.00111	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000121	0.00111	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.000119	0.00109	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000119	0.00109	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—NPS—narcolepsy	0.000119	0.00109	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HCRT—narcolepsy	0.000116	0.00106	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000113	0.00103	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TRH—narcolepsy	0.000111	0.00101	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00011	0.00101	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000109	0.000993	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000108	0.000991	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—NPS—narcolepsy	0.000108	0.00099	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TAC1—narcolepsy	0.000108	0.00099	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	0.000107	0.000977	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000107	0.000977	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000107	0.000977	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000106	0.000972	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	0.000105	0.000961	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	0.000105	0.000961	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.000105	0.000957	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000105	0.000956	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000105	0.000956	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PENK—narcolepsy	0.000104	0.000947	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000103	0.000943	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000103	0.000941	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000103	0.000941	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—P2RY11—narcolepsy	0.000101	0.000928	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000101	0.000923	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000101	0.000922	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	9.94e-05	0.000909	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRH3—narcolepsy	9.87e-05	0.000902	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRH3—narcolepsy	9.71e-05	0.000888	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRH3—narcolepsy	9.66e-05	0.000883	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—HTR2A—narcolepsy	9.58e-05	0.000876	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	9.51e-05	0.000869	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	9.38e-05	0.000858	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	9.3e-05	0.00085	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	9.23e-05	0.000844	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—NPS—narcolepsy	9e-05	0.000823	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TAC1—narcolepsy	9e-05	0.000823	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CHKB—narcolepsy	8.98e-05	0.000821	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	8.86e-05	0.00081	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—NPS—narcolepsy	8.86e-05	0.00081	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	8.81e-05	0.000806	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—NPS—narcolepsy	8.81e-05	0.000806	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TRH—narcolepsy	8.8e-05	0.000805	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HCRT—narcolepsy	8.77e-05	0.000802	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	8.67e-05	0.000793	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	8.67e-05	0.000793	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HCRT—narcolepsy	8.63e-05	0.000789	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HCRT—narcolepsy	8.58e-05	0.000785	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HCRT—narcolepsy	8.45e-05	0.000773	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TAC1—narcolepsy	8.18e-05	0.000748	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NPS—narcolepsy	8.18e-05	0.000748	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TAC1—narcolepsy	8.04e-05	0.000736	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NPS—narcolepsy	8.04e-05	0.000736	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TAC1—narcolepsy	8e-05	0.000732	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NPS—narcolepsy	8e-05	0.000732	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	7.88e-05	0.00072	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NPS—narcolepsy	7.88e-05	0.00072	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PENK—narcolepsy	7.82e-05	0.000715	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRH3—narcolepsy	7.72e-05	0.000706	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PENK—narcolepsy	7.69e-05	0.000703	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PENK—narcolepsy	7.65e-05	0.0007	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PENK—narcolepsy	7.53e-05	0.000689	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—HTR2A—narcolepsy	7.17e-05	0.000656	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TRH—narcolepsy	6.65e-05	0.000608	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TRH—narcolepsy	6.54e-05	0.000598	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HTR2A—narcolepsy	6.51e-05	0.000596	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TRH—narcolepsy	6.51e-05	0.000595	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TRH—narcolepsy	6.4e-05	0.000586	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TAC1—narcolepsy	6.4e-05	0.000585	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NPS—narcolepsy	6.4e-05	0.000585	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CPT1B—narcolepsy	6.1e-05	0.000558	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRH3—narcolepsy	5.83e-05	0.000533	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRH3—narcolepsy	5.73e-05	0.000524	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRH3—narcolepsy	5.7e-05	0.000522	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRH3—narcolepsy	5.62e-05	0.000513	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	5.42e-05	0.000495	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	5.3e-05	0.000485	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	5.22e-05	0.000477	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	4.97e-05	0.000455	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HTR2A—narcolepsy	4.92e-05	0.00045	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TAC1—narcolepsy	4.83e-05	0.000442	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NPS—narcolepsy	4.83e-05	0.000442	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	4.81e-05	0.00044	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NPS—narcolepsy	4.75e-05	0.000434	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TAC1—narcolepsy	4.75e-05	0.000434	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	4.74e-05	0.000433	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TAC1—narcolepsy	4.73e-05	0.000432	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NPS—narcolepsy	4.73e-05	0.000432	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NPS—narcolepsy	4.65e-05	0.000425	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TAC1—narcolepsy	4.65e-05	0.000425	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HTR2A—narcolepsy	3.85e-05	0.000352	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HTR2A—narcolepsy	2.91e-05	0.000266	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HTR2A—narcolepsy	2.84e-05	0.00026	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	2.8e-05	0.000256	CbGpPWpGaD
